Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes [22]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 3, 2007, Pages 421-423

  Feletti, Francesco ^a   Vincenzi, C ^a   Pazzaglia, M ^a   Tosti, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRAVOPROST;

ADULT; ALOPECIA AREATA; CASE REPORT; CLINICAL EXAMINATION; DRUG USE; DRUG WITHDRAWAL; EYELASH; FEMALE; FOLLOW UP; HAIR GROWTH; HUMAN; LETTER; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SKIN PIGMENTATION; TREATMENT DURATION;

ADULT; ALOPECIA AREATA; CHILD; CLOPROSTENOL; EYELASHES; FEMALE; HUMANS; MIDDLE AGED; PIGMENTATION DISORDERS;

EID: 33846987177     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01911.x     Document Type: Letter

References (6)

1. Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs. Surv Ophthalmol 2002; 47: 105-115.
2. Toris CB, Camras CB, Yablonski ME, Brubaker RF. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol 1997; 41: S69-S75.
3. Chiba T, Kashiwagi K, Kogure S et al. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Jpn J Ophthalmol 2004; 48: 141-147.
4. Herdnon L, Williams R et al. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans. Am J Opthalmol 2003; 135: 713-715.
5. Tosti A, Pazzaglia M, Voudouris S, Tosti G. Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol 2004; 51: 149-150.
6. Na GY, Kim do W, Lee SJ et al. Mutation in the ED1 gene, Ala349Thr, in a Korean patient with X-linked hypohidrotic ectodermal dysplasia developing de novo. Pediatr Dermatol 2004; 21: 568-572.